Jan 7, 2025 06:51AM

Dec 11, 2024 07:24AM

Nov 14, 2024 06:58AM

Aug 22, 2024 07:00AM

Aug 14, 2024 06:13AM

Aug 13, 2024 04:00PM

Aug 13, 2024 04:00PM ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

May 10, 2024 06:58AM

Sep 5, 2023 06:30AM

20,596 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All